GlassScriptPhysician profile
Sarah Salvaggio
NPI 1235532938
$3,847.39
in general payments reported to CMS, 2019-2025
17 companies · $1,028 in 2025
The $1,028 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $380 · 2022: $555 · 2023: $823 · 2024: $1,061 · 2025: $1,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,764 · Education: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,764.22 |
| Education | $147.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,096.80 | 2021-2025 | |
| Janssen Biotech, INC. | $1,074.67 | 2022-2025 | Tremfya |
| Lilly USA, LLC | $419.01 | 2022-2025 | Ebglyss, Taltz, Olumiant |
| Regeneron Healthcare Solutions, INC. | $357.75 | 2022-2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $210.53 | 2021-2025 | |
| Genzyme Corporation | $208.03 | 2021-2025 | |
| Amgen INC. | $115.88 | 2023-2025 | Otezla, Otezla |
| Leo Pharma INC. | $83.75 | 2025 | Adbry, Anzupgo |
| Dermavant Sciences, INC. | $62.21 | 2023 | Vtama |
| Arcutis Biotherapeutics, INC. | $49.36 | 2024-2025 | Zoryve |
| Ucb, INC. | $38.38 | 2025 | Bimzelx |
| Galderma Laboratories, L.P. | $30.26 | 2021-2022 | |
| Incyte Corporation | $25.47 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.60 | 2022 | |
| Botanix Sb INC | $21.19 | 2025 | Sofdra |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $16.00 | 2023 | |
| Sanofi-Aventis U.S. LLC | $14.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Salvaggio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.